1. Home
  2. ALT vs KLTR Comparison

ALT vs KLTR Comparison

Compare ALT & KLTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • KLTR
  • Stock Information
  • Founded
  • ALT 1997
  • KLTR 2006
  • Country
  • ALT United States
  • KLTR United States
  • Employees
  • ALT N/A
  • KLTR N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • KLTR EDP Services
  • Sector
  • ALT Health Care
  • KLTR Technology
  • Exchange
  • ALT Nasdaq
  • KLTR Nasdaq
  • Market Cap
  • ALT 292.0M
  • KLTR 302.6M
  • IPO Year
  • ALT N/A
  • KLTR 2021
  • Fundamental
  • Price
  • ALT $3.67
  • KLTR $1.59
  • Analyst Decision
  • ALT Strong Buy
  • KLTR Buy
  • Analyst Count
  • ALT 6
  • KLTR 3
  • Target Price
  • ALT $17.40
  • KLTR $2.83
  • AVG Volume (30 Days)
  • ALT 2.8M
  • KLTR 284.4K
  • Earning Date
  • ALT 08-12-2025
  • KLTR 08-07-2025
  • Dividend Yield
  • ALT N/A
  • KLTR N/A
  • EPS Growth
  • ALT N/A
  • KLTR N/A
  • EPS
  • ALT N/A
  • KLTR N/A
  • Revenue
  • ALT $20,000.00
  • KLTR $181,350,000.00
  • Revenue This Year
  • ALT N/A
  • KLTR $3.46
  • Revenue Next Year
  • ALT $761,880.20
  • KLTR $3.67
  • P/E Ratio
  • ALT N/A
  • KLTR N/A
  • Revenue Growth
  • ALT N/A
  • KLTR 2.56
  • 52 Week Low
  • ALT $2.90
  • KLTR $1.06
  • 52 Week High
  • ALT $11.16
  • KLTR $2.82
  • Technical
  • Relative Strength Index (RSI)
  • ALT 46.45
  • KLTR 45.80
  • Support Level
  • ALT $3.35
  • KLTR $1.38
  • Resistance Level
  • ALT $3.66
  • KLTR $1.51
  • Average True Range (ATR)
  • ALT 0.18
  • KLTR 0.10
  • MACD
  • ALT 0.05
  • KLTR 0.02
  • Stochastic Oscillator
  • ALT 58.57
  • KLTR 48.28

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

Share on Social Networks: